IVC Filter Lawsuit Center


The medical devices attorneys at Bernstein Liebhard LLP are investigating serious injury claims involving catastrophic failures of C.R. Bard’s Recovery IVC Filter and G2 IVC Filter systems. A growing number of Bard IVC filter lawsuits claim that these systems are defective, making them prone to fracture and migration. Such failures can cause a range of serious and potentially fatal injuries, including:

  • Internal hemorrhage
  • Cardiac tamponade
  • Severe pain
  • Tissue, blood vessel and organ perforations
  • Pulmonary embolism
  • Respiratory distress
  • Deep vein thrombosis in lower limbs
  • Death

If your or a loved one suffered any of these dangerous complications following the catastrophic failure of a Bard IVC filter, our attorneys would like to hear from you. Your pain and suffering could entitle you to compensation for medical bills, lost wages and any other damages you may have incurred. If you would like to learn more about the legal options available to the victims of Bard IVC filter injuries, please call to schedule your free, no obligation case review.

The attorneys at Bernstein Liebhard LLP are also investigating Nexium lawsuits and other proton pump inhibitor cases involving chronic kidney disease, nephritis, acute kidney injury and kidney failure. Recent studies suggest that heartburn drugs like Nexium, Prilosec and Prevacid can harm the kidneys, and a number of lawsuits have already been filed on behalf of patients who developed serious renal complications allegedly associated with their use. If you suffered similar harm after using a prescription or over-the-counter proton pump inhibitor, you must take appropriate steps to safeguard your legal rights. Please visit the Nexium Lawsuit Center to learn more and to arrange for a free legal review of your case.

History of Bard IVC Filters

The U.S. Food & Drug Administration (FDA) approved C.R. Bard’s Recovery IVC Filter in 2003. The device was intended to treat patients at risk for pulmonary embolism, but who are unable to use blood-thinning medications. Surgeons implant the filter into the inferior vena cava (IVC), where it catches blood clots before they reach the lungs and cause an embolism. The Recovery filter was designed as a short-term implant, and can be removed once the threat of pulmonary embolism has passed. Shortly after it was brought to market, studies began to emerge that suggested the Bard Recovery IVC Filter can break down over time and fracture in the body. Should this occur, pieces may travel to the heart or lungs, resulting in serious – and even deadly – injuries.  In 2005, Bard voluntarily ended sales of the Recovery IVC Filter and replaced it with the G2 IVC Filter system, which was supposed to be more resistant to fracture and migration. Unfortunately, studies have shown that the G2 IVC Filter may also  be prone to fracture and migration. Hundreds of people have filed Bard IVC filter lawsuits, all of which allege the devices are defective and unreasonably dangerously. Plaintiffs argue that Bard knew or should have known that its IVC filters were likely to fracture, tilt, perforate the vena cava wall and/or migrate, resulting in serious injury to patients. They further claim that the company failed to disclose these risks to doctors, patients and regulators, and continued to promote the IVC filters as safe, even after studies highlighted their potential risks. While C.R. Bard has settled some IVC filter lawsuits in recent years, dozens of claims remain to be litigated.

FDA IVC Filter Warnings

Since 2010, the FDA has issued two warnings regarding the risks potentially associated with retrievable IVC filters, such as the Bard Recovery and G2 systems. In 2010, the agency warned doctors that it had received 921 reports of adverse events linked to IVC filters, including 328 incidents of migration, 146 reports of fracture and embolization, 70 cases of inferior vena cava perforation, and 56 reports of filter fracture. In May 2014, the FDA issued a second alert emphasizing that retrievable IVC filters should be removed within 29 to 54 days after implantation. However, retrieval is not always possible, according a study involving 952 IVC filter patients that was published in JAMA: Internal Medicine in April 2013. Among other things, the study found that the filters were only successfully retrieved in 8.5% of the patients. Its authors also noted that 8% of the subjects experienced a deep vein thrombosis with the IVC filters in place, while 2.5% developed a pulmonary embolism.


Learn More about Filing a Bard IVC Filter Lawsuits

For more than 20 years, Bernstein Liebhard LLP has successfully represented the victims of defective medical devices. Our attorneys are ready to put their experience and resources to work for you, and will fight aggressively to ensure you are fairly compensated for all of your injuries and related damages. To learn more about filing a Bard IVC filter lawsuit, please contact our office today by calling .

Web Analytics